Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer

ShengYu Ku; Elena Lasorsa; Remi Adelaiye; Swathi Ramakrishnan; Leigh Ellis; Roberto Pili

doi:10.1371/journal.pone.0103680

Loading metrics

Open Access

Peer-reviewed

Research Article

Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer

ShengYu Ku,

Affiliations Genitourinary Program, Roswell Park Cancer Institute, Buffalo, New York, United States of America, Department of Cancer Prevention and Pathology, Roswell Park Cancer Institute, Buffalo, New York, United States of America
⨯
Elena Lasorsa,

Affiliations Genitourinary Program, Roswell Park Cancer Institute, Buffalo, New York, United States of America, Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America
⨯
Remi Adelaiye,

Affiliations Genitourinary Program, Roswell Park Cancer Institute, Buffalo, New York, United States of America, Department of Cancer Prevention and Pathology, Roswell Park Cancer Institute, Buffalo, New York, United States of America
⨯
Swathi Ramakrishnan,

Affiliations Genitourinary Program, Roswell Park Cancer Institute, Buffalo, New York, United States of America, Department of Cancer Prevention and Pathology, Roswell Park Cancer Institute, Buffalo, New York, United States of America
⨯
Leigh Ellis ,

* E-mail: Leigh.Ellis@roswellpark.org (LE); Roberto.Pili@roswellpark.org (RP)

Affiliations Genitourinary Program, Roswell Park Cancer Institute, Buffalo, New York, United States of America, Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America
⨯
Roberto Pili

* E-mail: Leigh.Ellis@roswellpark.org (LE); Roberto.Pili@roswellpark.org (RP)

Affiliations Genitourinary Program, Roswell Park Cancer Institute, Buffalo, New York, United States of America, Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, United States of America
⨯

Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer

ShengYu Ku,
Elena Lasorsa,
Remi Adelaiye,
Swathi Ramakrishnan,
Leigh Ellis,
Roberto Pili

Published: July 29, 2014
https://doi.org/10.1371/journal.pone.0103680

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Cell death
Is the Subject Area "Cell death" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Androgens
Is the Subject Area "Androgens" applicable to this article?

Thanks for your feedback.
Testicular cancer
Is the Subject Area "Testicular cancer" applicable to this article?

Thanks for your feedback.
Cell growth
Is the Subject Area "Cell growth" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.